Mesenchymal stem cells and management of COVID-19 pneumonia

por Metcalfe, Su M.
Publicado 2020

COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF)

por Metcalfe, Su M.
Publicado 2020

LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?

por Metcalfe, Su M
Publicado 2020

Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF

por Metcalfe, Su M., Strom, Terry B., Williams, Anna, Fahmy, Tarek M.
Publicado 2015

Multiple Sclerosis: LIFNano-CD4 for Trojan Horse Delivery of the Neuro-Protective Biologic “LIF” Into the Brain: Preclinical Proof of Concept

por de la Flor, Raul, Robertson, Janette, Shevchenko, Rostislav V., Alavijeh, Mo, Bickerton, Sean, Fahmy, Tarek, Metcalfe, Su M.
Publicado 2021

Modelling of a targeted nanotherapeutic ‘stroma’ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt–β-catenin signalling, for use in human fetal dopaminergic grafts...

por Zhao, Jing-Wei, Dyson, Sean C., Kriegel, Christina, Tyers, Pam, He, Xiaoling, Fahmy, Tarek M., Metcalfe, Su M., Barker, Roger A.
Publicado 2014

Immuno-Isolation of Pancreatic Islet Allografts Using Pegylated Nanotherapy Leads to Long-Term Normoglycemia in Full MHC Mismatch Recipient Mice

por Dong, Huansheng, Fahmy, Tarek M., Metcalfe, Su M., Morton, Steve L., Dong, Xiao, Inverardi, Luca, Adams, David B., Gao, Wenda, Wang, Hongjun
Publicado 2012